Navigation Links
OmniPod(R) Insulin Management System Selected as a Finalist for the 2009 Edison Best New Product Awards(TM)

Prestigious Awards Recognize Excellence in New Product Development, Marketing and Innovation

BEDFORD, Mass., Feb. 11 /PRNewswire-FirstCall/ -- The OmniPod(R) Insulin Management System, designed and produced by Insulet Corporation (Nasdaq: PODD), has been selected as a finalist for the prestigious 2009 Edison Best New Product AwardsTM. The awards are among the most elite accolades honoring excellence in new product development, marketing, and innovation. Strategic implementation partners for the 2009 awards program include the Thomas Edison Papers at Rutgers University, the Marketing Executives Networking Group (MENG) and The MIT/Stanford Venture Lab (VLAB).

The OmniPod(R) Insulin Management System is the first and only continuous insulin delivery system of its kind on the market. The OmniPod System offers people living with insulin-requiring diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease in managing their diabetes. Unlike conventional insulin pumps, the OmniPod System has no tubing and features automated, virtually pain-free insertion. It has just two, wireless components: the Pod - a, compact, lightweight, self-adhesive insulin delivery device that is worn discreetly on the skin beneath clothing; and the Personal Diabetes Manager - a wireless, menu-driven, hand-held device that programs the Pod.

The Edison Best New Product Awards, sponsored this year by Google, The Nielsen Company and Steelcase, focus on new products and services that excel in marketplace innovation, marketplace success, technological innovation, market structure innovation, and societal impact. These criteria align with Edison's own innovation best practices, called the Five Competencies of Innovation. MENG members nationwide cast their ballots for entries they deemed worthy of being linked to the Edison name.

"We are honored that the OmniPod System has been recognized for its innovative design and the positive impact it has on the lives of people with diabetes," said Duane DeSisto, president and CEO of Insulet Corporation. "When we created the OmniPod, we started with a blank slate and took a customer-centric approach to designing a new insulin delivery system. Its tubing-free, wireless design makes it totally discreet and the Pod is watertight and durable enough to be worn by many professional athletes. The OmniPod's automated, virtually pain-free insertion means customers never see or handle an insertion needle."

"Innovative, collaborative, passionate, and persistent are just a few of the many characteristics that describe the finalists for the 2009 Edison Best New Product Awards," stated Sarah Miller Caldicott, great grandniece of Thomas Edison, co-author of Innovate Like Edison and Chairperson of the Edison Awards Steering Committee. "All of our 2009 finalists, each in different ways, exemplify the very best in innovation."

Gold, Silver and Bronze winners will be announced at an Awards Gala on April 1, 2009 at the Computer History Museum in Mountain View, California. To register to attend, visit

About The Edison Awards:

The Edison Best New Products Award(TM) recognizes the persistence and excellence Thomas Edison personified, qualities which have allowed America to remain in the forefront of innovation, creativity, and ingenuity in the global economy. The Edison Achievement Award(TM) honors business leaders who have displayed the persistence, collaboration, and creativity necessary to promote successful innovation in their organizations. For more information about The Edison Awards, visit

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

    Media Contacts:
    Mark Sahl on behalf of Insulet

    Chris Faust on behalf of The Edison Awards

SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R)
2. Insulin May Protect Against Alzheimers
3. Intensive Insulin Therapy Reduces Mortality in Sick Kids
4. High insulin levels raise risk of breast cancer in postmenopausal women
5. High Insulin May Boost Odds of Breast Cancer
6. Vitamin K Slows Insulin Resistance in Older Men
7. Vitamin K linked to insulin resistance in older men
8. Lilly Announces Major Donation of Insulin to International Diabetes Federations Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa
9. Completely novel action of insulin unveiled
10. Impact of insulin pump under study
11. Diabetes Spectrum Reports a Study Assessing the i-port(R) Injection Port for Administration of Insulin
Post Your Comments:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... offering factory direct sauna parts and accessories. , Sauna accessories help improve ... the bather’s style and personality. From basic styles for the purist looking for ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... For the ... companies’ “ Two Organizations, One Beat ” campaign. The partnership between the two groups ... to aid in MAP International’s cause. , MAP International was founded in 1954 and ...
(Date:11/25/2015)... ... 2015 , ... On November 25, 2015, officials of Narconon Arrowhead , ... release of a new cutting edge recovery program that has been 50 years in ... and alcohol-addicted individuals with the purpose to free addicts from the symptoms and negative ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens is ... and moderate facial wrinkling. While many patients are aware of the benefits of Botox® ... Botox® delivers to those suffering with discomfort, soreness, and pain as a result of ...
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, MD, ... the efficacy of its product and its disinfection protocol. This study is taking place ... through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, Illinois. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Japanese therapeutic drug monitoring ...
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... -- ) has announced the ... Viscosity Drugs" report to their offering. ... of the "Self Administration of High Viscosity ... Research and Markets ( ) has ... of High Viscosity Drugs" report to their ...
Breaking Medicine Technology: